This NDC is on FDA's drug shortage list (posted Mar 3, 2025)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT is a generic product labeled by Padagis US LLC, priced at $29.6259 per GM under NDC 00574402235. Its NADAC has been published 588 times since May 14, 2014.
FDA first approved this application before 1982.
The High Outlier badge above means this manufacturer's average price in the Bacitracin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
500 [USP'U]/g
Manufacturer
Padagis US LLCNDC
00574402235
Classification
Generic
Dosage Form
OINTMENT
Route
OPHTHALMIC
Effective Date
5/21/2025
Active Ingredients
BACITRACINApproval Type
Generic (ANDA)
FDA Application
ANDA061212FDA Approved
Before 1982
On Market Since
3/10/2014
Pharmacological Classes
Price Statistics
The NADAC for BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT has been published 588 times since May 14, 2014, and over the history we have for it it has risen 82.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $29.6259 per GM |
|---|---|
| All-time high | $30.8706 (Oct 11, 2023) |
| All-time low | $16.2054 (May 14, 2014) |
| 52-week high | $29.6259 |
| 52-week low | $29.6259 |
| Median price | $26.8574 |
| Average price | $26.0866 |
| Largest weekly change | +20.0% (Nov 18, 2015) |
| Weeks tracked | 588 |
| Tracking since | May 14, 2014 |
1W
N/A
1M
N/A
3M
N/A
6M
0.0%
1Y
0.0%
3Y
-4.0%
5Y
+13.7%
All
+82.8%
Last surveyed May 13, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT?
The current National Average Drug Acquisition Cost (NADAC) for BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT, manufactured by Padagis US LLC, is $29.6259 per GM (NDC 00574402235), effective May 13, 2026.
How has the price of BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT changed over time?
Over the history we have for it, the NADAC for BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT has risen 82.8%. It has been tracked across 588 weekly CMS publications since May 14, 2014.
What are the highest and lowest recorded NADAC prices for BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT?
Since May 14, 2014, the NADAC for BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT has ranged from a low of $16.2054 (May 14, 2014) to a high of $30.8706 (Oct 11, 2023), with a median of $26.8574 per GM.
Are there cheaper alternatives to BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, BACITRACIN 500 UNIT/GM OINTMNT, is $0.0740 per GM — about 99% below BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT.
Who manufactures BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT?
BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT (NDC 00574402235) is labeled by Padagis US LLC, and CMS classifies it as a generic product.
Is BACITRACIN 500 UNIT/GM OPHTHALMIC OINTMENT in shortage?
Yes — NDC 00574402235 is currently listed in FDA's drug shortage database (posted Mar 3, 2025). Reported reason: Discontinuation of the manufacture of the drug.